Filing Flows › Ironwood Pharmaceuticals (IRWD) › Stock forecast & fair value
Ironwood Pharmaceuticals (IRWD) stock forecast and price target
Ironwood Pharmaceuticals (IRWD) trades at $4.39. 4 analysts' median price target is $5.35 (+22%), from $3.70 to $10.00.
Ironwood Pharmaceuticals' latest quarter
Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for IRWD stock?
The median of 4 analysts' 12-month targets is $5.35, +22% from $4.39; the range is $3.70 to $10.00. The average rating is none.
Does Ironwood Pharmaceuticals usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is IRWD stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.